Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating high-intensity focused ultrasound for unresectable pancreatic cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating the combination of an anti-PD-1 antibody with chemotherapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating a biologically optimized infusion schedule of gemcitabine and nab-paclitaxel for metastatic pancreatic can…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NT-I7 (efineptakin alfa) in combination with pembrolizumab in adults with advanced solid tumors has completed and…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating irreversible electroporation in combination with pembrolizumab in locally advanced pancreatic cancer has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study [EARLY_Phase 1]
An early Phase 1 study called CARES evaluating cancer coaching and remote education for self-empowerment in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma [NA]
This completed study evaluates the correlation between portal and peripheral venous circulating tumor DNA in pancreatic cancer to assess its…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
This clinical trial update reports a preliminary evaluation of screening for pancreatic cancer in individuals with inherited genetic risk an…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery [Phase 1]
This is a Phase 1 clinical trial evaluating a combination of gemcitabine hydrochloride, paclitaxel albumin-stabilized nanoparticle formulati…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating FG-M108 in combination with chemotherapy versus placebo with chemotherapy for Claudin18.2-positive pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Second Opinions in Oncology
This is a completed clinical trial update on second opinions in oncology conducted by the University of Colorado, Denver. The study involves…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface [Phase 1]
A Phase 1 study evaluating different doses of BI-765049 alone and in combination with Ezabenlimab in patients with advanced solid tumors exp…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: CAR T Cell Immunotherapy for Pancreatic Cancer [Phase 1]
Phase 1 clinical trial of CAR T cell immunotherapy for pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]
Phase 1 dose-finding study evaluating safety, tolerability, and pharmacokinetics of SNB-101 (SN-38) in patients with colorectal, breast, pan…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study [Phase 1, Phase 2]
A single-arm Phase 1/2 trial evaluating low-dose radiotherapy in combination with pucotenlimab and standard therapy for advanced pancreatic …
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial assessing paricalcitol and hydroxychloroquine in combination with gemcitabine and nab-paclitaxel for advanced pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study of TAK-500 with or without pembrolizumab in adults with select locally advanced or metastatic solid tumors; the trial was …
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers [Phase 1]
Phase 1 trial evaluating a WT1-targeted immunotherapy in HLA-A*0201+ WT1+ recurrent/metastatic cancers has completed, including colorectal c…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer [Phase 2]
Phase 2 trial comparing oral cryotherapy with acupressure/acupuncture versus oral cryotherapy alone to prevent oxaliplatin-induced periphera…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder [Phase 2]
Phase 2 study update on brigimadlin (BI 907828) in biliary tract cancer, pancreatic cancer, lung cancer, and bladder cancer; the trial has c…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone [NA]
A completed clinical trial comparing minimally invasive versus open pancreaticoduodenectomy for pancreaticobiliary cancers.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase Ib/II clinical trial is evaluating the safety and efficacy of IBI363 in combination with chemotherapy as second-line therapy for unr…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate [Phase 2]
A Phase 2 clinical trial evaluating DZ-002, a heptamine carboxymethine dye conjugate, as maintenance therapy for metastatic pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer [Phase 2]
Phase 2 NeoOPTIMIZE trial evaluating upfront switching between mFOLFIRINOX and Gemcitabine/Nab-Paclitaxel before surgery for resectable to u…